title: Management of Type 2 Diabetes in 2017: Getting to Goal.
authors.affiliation: Center for Women's Health Research, Anschutz Medical Center, University of Colorado, Denver2Denver VA Medical Center, Denver, Colorado.
authors.forename: Jane E B
authors.initials: JE
authors.lastname: Reusch
authors.affiliation: Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts4Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
authors.forename: JoAnn E
authors.initials: JE
authors.lastname: Manson
mesh_terms: D001786:Blood Glucose / Q000378:metabolism; D003131:Combined Modality Therapy; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D019468:Disease Management; D006442:Glycated Hemoglobin; D006040:Goals; D000070497:Healthy Lifestyle; D006801:Humans; D006943:Hyperglycemia / Q000097:blood / Q000628:therapy*; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D054795:Incretins / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D008687:Metformin / Q000627:therapeutic use; D018802:Patient-Centered Care; D000077203:Sodium-Glucose Transporter 2 Inhibitors
chemical_list: D001786:Blood Glucose; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D054795:Incretins; D007328:Insulin; D008687:Metformin; D000077203:Sodium-Glucose Transporter 2 Inhibitors